Patents Represented by Attorney Patricia L. Chisholm
  • Patent number: 8273908
    Abstract: Process for the preparation of a compound of general formula (II) wherein R1 and R2 independently are hydrogen or a hydroxy- or hydrocarbyl group; or wherein R1 and R2 together are a double bonded oxygen; R3 is hydrogen; R?4 is a nitrobenzophenone group; and R5 and R6 independently are hydrogen or a hydroxy- or hydrocarbyl group; from a compound of general formula (I) wherein, R1, R2 R3, R5 and R6 are as defined above and R4 is hydrogen; wherein the compound of formula (I) is reacted under alkaline conditions with 2-chloro-5-nitrobenzophenone in the presence of an alkanolic solvent and the compound of formula (II) is directly crystallized from this alkanolic solvent. Complex of an alkanol and a compound of general formula (II) obtainable from the above process and processes wherein the above process or complex are used.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: September 25, 2012
    Assignee: MSD Oss B.V.
    Inventors: Lambertus Gerardus Maria Willems, Henricus Johannes Franciscus Maas, Martin Ostendorf
  • Patent number: 7994293
    Abstract: Antibodies specific for Dkk-1, an inhibitor of the osteoanabolic Wnt/LRP5 signaling pathway, are described. The antibodies, which inhibit binding of Dkk-1 to LRP5, are useful in compositions for stimulating bone growth, in particular, compositions for treating bone disorders which result in a loss in bone, for example, osteoporosis.
    Type: Grant
    Filed: February 6, 2008
    Date of Patent: August 9, 2011
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Zhiqiang An, Fang Chen, John E. Fisher, Helmut Glantschnig, Donald B. Kimmel, Alfred A. Reszka, Fubao Wang
  • Patent number: 7910350
    Abstract: The present invention provides adapter-directed display systems for expressing exogenous polypeptide within a host cell and/or displaying the exogenous polypeptide on the outer surface of a genetic package. This subject systems are particularly useful for displaying a genetically diverse repertoire of monomeric and multimeric polypeptides. The invention also provides both expression and helper vectors and kits containing components of the subject display systems. Also provided are genetic packages displaying the exogenous polypeptides of particular interest. Further provided by the invention are methods of using the subject display systems.
    Type: Grant
    Filed: December 19, 2005
    Date of Patent: March 22, 2011
    Assignee: Abmaxis, Inc.
    Inventors: Caili Wang, Pingyu Zhong, Xinwei Wang
  • Patent number: 7622553
    Abstract: The present invention provides rhesus monkey dickkopf-1 (rhDkk-1) and nucleotide sequences encoding it. Also provided herein are recombinant vectors, and recombinant hosts comprising rhDkk-1-encoding nucleotide sequences. Isolated rhDkk-1 can be used to screen and identify novel osteoanabolic compounds that stimulate bone formation for the treatment of osteoporosis or other disorders characterized by insufficient bone mass.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: November 24, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Shun-ichi Harada, Viera Kasparcova, Helmut Glantschnig
  • Patent number: 7611851
    Abstract: A Canis sphingosine-1-phosphate (S1P) receptor isoform 1 (cS1P1), the nucleic acid encoding the cS1P1 receptor, and methods for using the cS1P1 receptor and the nucleic acid encoding the cS1P1 receptor in assays for identifying analytes which modulate activity of the cS1P1 receptor.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: November 3, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Suzanne M. Mandala, Cheryl Meyers, Gan-Ju Maria Shei
  • Patent number: 7473770
    Abstract: The cynomolgus monkey Dickkopf-4 (cDkk-4) protein, isolated nucleic acid molecules which encode the cDkk-4 protein, and recombinant vectors and hosts comprising DNA encoding the cDkk-4 protein are disclosed. Also disclosed are methods for identifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor and analytes which interfere with the interaction and stimulate bone formation. Analytes identified using the methods are useful for treating osteoporosis and other bone loss disorders.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: January 6, 2009
    Assignee: Merck & Co., Inc.
    Inventors: Shun-ichi Harada, Viera Kasparcova, Helmut Glantschnig
  • Patent number: 7429652
    Abstract: The present invention provides a technique for specific assembly of monomeric polypeptides to form a heteromultimer. This technique is particularly useful for generating a genetically diverse repertoire of heteromultimers such as antigen-binding units. The invention also provides both non-single-chain and single-chain antigen-binding units that are assembled by the technique described herein. The present invention also provides recombinant polynucleotides, vectors, host cells, and kits for producing the subject antigen-binding units. Further provided by the invention are methods of using the subject antigen-binding units.
    Type: Grant
    Filed: August 3, 2004
    Date of Patent: September 30, 2008
    Assignee: Abmaxis, Inc.
    Inventors: Caili Wang, Pingyu Zhong, Shengjiang Liu, Peizhi Luo, Shengfeng Li, Xinwei Wang
  • Patent number: 7175983
    Abstract: The present invention provides adapter-directed display systems for expressing exogenous polypeptide within a host cell and/or displaying the exogenous polypeptide on the outer surface of a genetic package. This subject systems are particularly useful for displaying a genetically diverse repertoire of monomeric and multimeric polypeptides. The invention also provides both expression and helper vectors and kits containing components of the subject display systems. Also provided are genetic packages displaying the exogenous polypeptides of particular interest. Further provided by the invention are methods of using the subject display systems.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: February 13, 2007
    Assignee: Abmaxis, Inc.
    Inventors: Caili Wang, Pingyu Zhong, Xinwei Wang
  • Patent number: 6861516
    Abstract: Polynucleotides and polypeptides of Pseudomonas aeruginosa MraY, an enzyme involved in bacterial cell wall biosynthesis, are provided. The recombinant MraY enzyme is catalytically active in the first step of the membrane cycle of peptidoglycan biosynthesis. Also provided are proteins encoded by the sequences, host cells expressing the recombinant enzyme, and probes and primers.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: March 1, 2005
    Assignee: Merck & Co., Inc.
    Inventors: Mohamed El-Sherbeini, Barbara A. Azzolina